Harvard Business School’s Kraft Precision Medicine Accelerator announced the launch of a playbook specifically developed to bring vital assistance to over 20,000 organizations focused on diseases such as cancer. The playbook will be accessible to all organizations free of cost and is aimed to democratize cures by helping organizations build better, faster business models for finding cures and bringing them to market more efficiently.
“From Blueprint Medicines to Peloton to Pfizer, and from Marriott to Mass General, we heard insights to improve customer experience and drive results,” said Kathy Giusti, co-chair of the Accelerator and founder of the Multiple Myeloma Research Foundation. “As a result, we’ve reimagined the business model for disease-focused non-profits to include game changing business plans and models.”
The Kraft Precision Medicine Accelerator was established in 2016 to furnish and advance opportunities in precision medicine. Find out more about the Kraft Precision Medicine Accelerator and playbook here.
(Source: Harvard Business School Kraft Precision Medicine Accelerator, August 12, 2020)